| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.046 | 0.4 |